[ESPR] QoQ Quarter Result on 30-Jun-2020 [#Q2]

Stock
[ESPR] Esperion Therapeutics, Inc.
Announcement Date
10-Aug-2020
Financial Year
2020
Quarter
30-Jun-2020 [#Q2]
Profit Trend
QoQ- 259.25%
YoY- 329.82%
Quarter Report
ESPR's Result
ESPR's Financial Summary
View:
Show?
Quarter Result
31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 CAGR
Revenue 7,978 9,638 3,833 212,236 1,840 982 981 303.88%
PBT -90,935 -104,476 -85,437 124,611 -78,249 -61,946 -68,377 20.91%
Tax 8,139 8,795 4,970 4,721 4,539 5,165 5,383 31.70%
NP -90,935 -104,476 -85,437 124,611 -78,249 -61,946 -68,377 20.91%
Tax Rate - - - -3.79% - - - -
Total Cost 98,913 114,114 89,270 87,625 80,089 62,928 69,358 26.67%
Ratio Analysis
31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 CAGR
NP Margin -1,139.82 -1,084.00 -2,228.99 58.71 -4,252.66 -6,308.15 -6,970.13 -70.06%
Per Share
31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 CAGR
EPS -3.50 -3.89 -3.07 4.50 -2.84 -2.26 -2.52 24.45%
EPS Diluted -3.50 -3.89 -3.07 4.32 -2.84 -2.26 -2.52 24.45%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.